Compass Financial Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Compass Financial Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146K	Buy	+588	New	+$127K	0.02%	482

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Compass Financial Management's FBT Position: Q2 2026 in Review

Compass Financial Management opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 588 shares worth $146K. The stake represents 0.02% of the portfolio and ranks #482 among its holdings.

326 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Compass Financial Management held 588 shares of First Trust NYSE Arca Biotechnology Index Fund worth $146K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Compass Financial Management position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Compass Financial Management's portfolio in Q2 2026, its #482 holding.
326 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.